His primary scientific interests are in COPD, Internal medicine, Surgery, Intensive care medicine and Randomized controlled trial. His COPD research is multidisciplinary, incorporating perspectives in Exacerbation, Physical therapy, Lung and Pulmonary function testing. His research in Internal medicine intersects with topics in Gastroenterology, Placebo and Cardiology.
His Surgery study combines topics in areas such as Respiratory disease, Quality of life, Endobronchial valve and Lung volume reduction surgery. The various areas that Gerard J. Criner examines in his Intensive care medicine study include Pulmonary disease, Guideline, Disease and Psychological intervention. His Randomized controlled trial study combines topics from a wide range of disciplines, such as Clinical trial, Pulmonary rehabilitation and Hazard ratio, Confidence interval.
Gerard J. Criner mainly focuses on COPD, Internal medicine, Intensive care medicine, Cardiology and Surgery. The COPD study which covers Spirometry that intersects with FEV1/FVC ratio. When carried out as part of a general Internal medicine research project, his work on Lung, Cohort and Fluticasone propionate is frequently linked to work in In patient, therefore connecting diverse disciplines of study.
In his work, Respiratory failure is strongly intertwined with Mechanical ventilation, which is a subfield of Intensive care medicine. His Surgery research incorporates elements of Respiratory disease, Anesthesia and Lung volume reduction surgery. His study in Lung volume reduction surgery is interdisciplinary in nature, drawing from both Pulmonary function testing and Pneumonectomy.
The scientist’s investigation covers issues in Internal medicine, COPD, Pneumonia, Exacerbation and In patient. His Internal medicine study frequently links to related topics such as Gastroenterology. His COPD research integrates issues from Spirometry, Clinical trial, Intensive care medicine and Fluticasone propionate.
His Pneumonia study which covers Mechanical ventilation that intersects with Respiratory failure. His Exacerbation research is multidisciplinary, incorporating perspectives in Rate ratio, Quality of life and Lung function. Gerard J. Criner combines subjects such as Disease progression, Lung volume reduction surgery and Cardiology with his study of Pulmonary disease.
Gerard J. Criner mostly deals with Internal medicine, COPD, Pneumonia, Exacerbation and Intensive care medicine. His work on Cohort, Pulmonary disease, Clinical endpoint and Hazard ratio as part of general Internal medicine study is frequently linked to In patient, therefore connecting diverse disciplines of science. His COPD study combines topics in areas such as Clinical trial, Fluticasone propionate, Gastroenterology and Lung, Lung function.
His Pneumonia research includes themes of Tocilizumab, Mechanical ventilation and Incidence. The Mechanical ventilation study combines topics in areas such as Retrospective cohort study and Respiratory failure. His research is interdisciplinary, bridging the disciplines of Protocol and Intensive care medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Claus F. Vogelmeier;Gerard J. Criner;Fernando J. Martinez;Antonio Anzueto.
American Journal of Respiratory and Critical Care Medicine (2017)
Azithromycin for Prevention of Exacerbations of COPD
Richard K. Albert;Richard K. Albert;John Connett;William C. Bailey;Richard Casaburi.
The New England Journal of Medicine (2011)
Chronic obstructive pulmonary disease phenotypes: the future of COPD.
Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli.
American Journal of Respiratory and Critical Care Medicine (2010)
Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society
Amir Qaseem;Timothy J. Wilt;Steven E. Weinberger;Nicola A. Hanania.
Annals of Internal Medicine (2011)
Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome : Results of a randomized phase II trial
R P Dellinger;J L Zimmerman;R W Taylor;R C Straube.
Critical Care Medicine (1998)
A randomized study of endobronchial valves for advanced emphysema.
Frank C. Sciurba;Armin Ernst;Felix J.F. Herth;Charlie Strange.
The New England Journal of Medicine (2010)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
Dave Singh;Alvar Agusti;Antonio Anzueto;Peter J. Barnes.
European Respiratory Journal (2019)
Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial.
Robert W. Taylor;Janice L. Zimmerman;R. Phillip Dellinger;Richard C. Straube.
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
David A. Lipson;Frank Barnhart;Noushin Brealey;Jean Brooks.
The New England Journal of Medicine (2018)
Predictors of mortality in patients with emphysema and severe airflow obstruction.
Fernando J. Martinez;Gregory Foster;Jeffrey L. Curtis;Gerard Criner.
American Journal of Respiratory and Critical Care Medicine (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: